RxDoctor Payments Data

Sarit Hovav

Psychiatry · Omaha, NENPI 1326489550

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $278,496 of the $306,949 with a category attached, or 90.7%. AbbVie accounts for 94.1% of it on its own, with 15 other manufacturers making up the rest. Among psychiatry clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$306,949in general payments, 2019–2025

Across 433 payments — averaging $708.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$289K
  • Alkermes, Inc.$17K
  • Tris Pharma Inc$259
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$224
  • Merz North America, Inc.$194
  • Axsome Therapeutics, Inc.$170
  • plus $541 from 10 others

What the payments were for

  • Speaking & faculty fees$278,49691%
  • Travel & lodging$22,2187%
  • Food & beverage$6,1022%
  • Education$1330%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$306,949 in reported general payments places this provider in the 95th percentile of 160 psychiatry providers in Nebraska.

See all psychiatry providers in Nebraska

Other psychiatry in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →